Best Buy will soon offer a convenient way for eligible customers to get prescription continuous glucose monitoring systems delivered right to their home. Facilitated by Wheel and HealthDyne, Best Buy will sell the Dexcom G7 Continuous Glucose Monitoring System to eligible customers through BestBuy.com, where they will be brought to our new platform, Wellness.BestBuyHealth.com to complete the process. Leveraging the Salesforce platform, Best Buy is selling glucose monitors via a site powered by Commerce Cloud. With more CGM system options aimed to come soon after launch, this is the first time the company will offer prescription based medical devices to customers.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on BBY:
- Best Buy price target lowered to $74 from $80 at Truist
- Fly Insider: HighPeak Energy, Signet among week’s notable insider trades
- Wallbox announces nationwide expansion with Best Buy for Pulsar Plus EV chargers
- Best Buy price target raised to $80 from $77 at Truist
- Best Buy price target raised to $85 from $78 at Telsey Advisory
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue